Oseltamivir and G6PD deficiency by Şinasi Özsoylu
To the Editor,
In the recent issue of the Journal, Dr. Akar sug-
gested that oseltamivir might be used safely in patients 
with glucose-6-phosphate dehydrogenase (G6PD) defi-
ciency [1]. 
Since the substances that decrease reduced gluta-
thione and membrane stability (by oxidation) are respon-
sible for hemolysis in G6PD deficiency, I am interested 
to learn the reasoning for the oseltamivir reaction if it 
caused hemolysis?
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We thank Prof. Dr. Özsoylu for his question concern-
ing our letter that was written due to the non-existent in-
formation on oseltamivir usage in glucose-6-phosphate 
dehydrogenase (G6PD)-deficient individuals [1]. Dr. Öz-
soylu wondered about the possible mechanism of os-
eltamivir that may be responsible for the hemolysis in 
G6PD-deficient individuals.
Following oral administration of oseltamivir, after 
de-esterification of the compound, primarily the active 
metabolite oseltamivir carboxylate is produced. Other 
metabolites-oseltamivir phosphate, D3-oseltamivir 
phosphate, and D3-oseltamivir carboxylate - have since 
been detected [2,3]. There is at present no informa-
tion on the possible effects of these compounds on the 
G6PD pathway. As a result, G6PD-deficient individuals 
have been excluded during the pharmacokinetic studies 
of oseltamivir [2]. 
As we stated previously, further studies are needed 
on this subject.
Sincerely,
Nejat Akar MD, Prof., 
MESA Hospital, Ankara, Turkey 
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